DE-A1- 19 523 502 (B1)

DE-A1- 19 849 650 (B1)

LEMCKE P K ET AL: "Spinally mediated opioid antidiarrheal effects" EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL LNKD- DOI:10.1016/0014-2999(91)90208-8, vol. 193, no. 1, 25 January 1991 (1991-01-25), pages 109-115, XP025547392 ISSN: 0014-2999 [retrieved on 1991-01-25] (B1)

SHOOK JENNIFER E ET AL: "Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation" JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 249, no. 1, 1 April 1989 (1989-04-01) , pages 83-90, XP009132309 ISSN: 0022-3565 (B1)

WO-A1-2005/046687 (B1)

SZARKA LAWRENCE A ET AL: "Efficacy of the peripheral kappa opioid agonist, asimadoline, on pain episodes of moderate severity in females with irritable bowel syndrome: A randomized, placebo-controlled, on-demand study", GASTROENTEROLOGY,, vol. 132, no. Suppl.4, 1 April 2007 (2007-04-01), pages A684-A685, XP009145851, (B1)

US-A1- 2005 176 746 (B1)

US-A1- 2007 010 450 (B1)

US-B2- 7 164 021 (B1)

SZARKA ET AL: "Efficacy of On-Demand Asimadoline, a Peripheral kappa-Opioid Agonist, in Females With Irritable Bowel Syndrome", CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, AMERICAN GASTROENTEROLOGICAL ASSOCIATION, US, vol. 5, no. 11, 1 November 2007 (2007-11-01), pages 1268-1275, XP022347341, ISSN: 1542-3565, DOI: DOI:10.1016/J.CGH.2007.07.011 (B1)